Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin PK in obese children 6-11 years
NCT02398669Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lorcaserin in obesity, sponsored by Eisai Co., Ltd. Primary endpoint: Plasma PK profile of lorcaserin and its primary metabolites (M1 and M5) at Day 5. Started Mar 2015; status: completed.
02
Drugs
lorcaserin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02398669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02398669.